Pfizer COVID-19 vaccine more than 90 percent effective – Interim analysis
by Press Release from Outbreak News Today on (#5A5NT)
Pfizer Inc. and BioNTech SE today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study. [...]
The post Pfizer COVID-19 vaccine more than 90 percent effective - Interim analysis appeared first on Outbreak News Today.